Biomea Fusion Stock (NASDAQ: BMEA) stock price, news, charts, stock research, profile.
You can purchase shares of Biomea Fusion (NASDAQ:BMEA) through any online brokerage.
Other companies in Biomea Fusion’s space includes: Renovaro (NASDAQ:RENB), Atossa Therapeutics (NASDAQ:ATOS), Adaptimmune Therapeutics (NASDAQ:ADAP), Kyverna Therapeutics (NASDAQ:KYTX) and TScan Therapeutics (NASDAQ:TCRX).
Biomea Fusion has a consensus price target of $34.59.
The stock price for Biomea Fusion (NASDAQ: BMEA) is $3.68 last updated February 21, 2025 at 9:13 AM EST.
There are no upcoming dividends for Biomea Fusion.
Biomea Fusion’s Q1 earnings are confirmed for Thursday, May 1, 2025.
There is no upcoming split for Biomea Fusion.
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.